Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR

Gene Therapy

Volumn 7, Issue 16, 2000, Pages 1369-1377

  Willemsen, R A ^a   Weijtens, M E M ^a   Ronteltap, C ^a   Eshhar, Z ^b   Gratama, J W ^a   Chames, P ^c   Bolhuis, R L H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chimeric; HLA A1; MAGE A1; T cell receptor; T lymphocytes

Indexed keywords

CD3 ANTIGEN; HLA ANTIGEN CLASS 1; LYMPHOKINE; PEPTIDE; POLYCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR REJECTION ANTIGEN; VIRUS VECTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CLONE; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; GENE CONSTRUCT; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE;

UNIDENTIFIED RETROVIRUS;

EID: 0033849524     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301253     Document Type: Article

References (41)

1. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report
2. Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen
3. Hybrid antibodies can target sites for attack by T cell
4. Optimization of culture conditions for activation and large scale expansion of human T lymphocytes for bispecific antibody-directed cellular immunotherapy
5. Regression of advanced ovarium carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody
6. New simplified molecular design for functional T cell receptor
7. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptor
8. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain
9. Single chain Ig/γ gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity
10. Adoptive transfer of in vitro-targeted activated T lymphocytes results in total tumor regression
11. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes
12. Clustered CD3/TCR complexes do not transduce activation signals after bispecific monoclonal antibody-triggered lysis by cytotoxic T lymphocytes via CD3
13. Human tumor antigens recognized by T lymphocytes
14. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
15. The roles of CD8 in cytotoxic T lymphocyte function
16. High-efficiency expression and solubilization of functional T cell antigen receptor heterodimers
17. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen
18. Functional three-domain single-chain T-cell receptors
19. Chimeric scFv/γ receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory molecules
20. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways
21. T-cell and basophil activation through the cytoplasmic tail of T-cell receptor ζ family proteins
22. Structural mutations of the T cell receptor ζ chain and its role in T cell activation
23. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes
24. High-efficient gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments
25. Fidelity of T cell activation through multistep T cell receptor ζ phosphorylation
26. Relationships among TCR ligand potency, thresholds for effector elicitation, and the quality of early signaling events in human T cells
27. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
28. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: Dose effects and involvement of both CD4 and CD8 T cells
29. Genetic re-targeting of T lymphocyte specificity
30. Restoration of viral immunity in immuno-deficient humans by adoptive transfer of T cell clones
31. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2
32. Phenotypic analysis of antigen-specific T lymphocytes
33. Selection of functional T cell receptor mutants from a yeast surface-display library
34. Display of functional alpha beta single-chain T cell receptor molecules on the surface of bacteriophage
35. A transient three-plasmid expression system for the production of high titer retroviral vectors
36. Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody
37. HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides
38. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies
39. Rapid expansion of human cytotoxic T cell clones: Growth promotion by a heat-labile serum component and by various types of feeder cells
40. Rapid expansion of allospecific cytotoxic T cell clones using nonspecific feeder cell lines without further addition of exogenous IL2
41. Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production